Autoplaque vs Cardiologs Holter Platform
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if your primary need is detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for clinicians focused on precise heart attack risk prediction and guiding treatment strategies based on the structural assessment of coronary artery disease.
View Autoplaque →Choose Cardiologs Holter Platform if…
Choose the Cardiologs Holter Platform if you require a fast, accurate, and cloud-based solution for analyzing Holter ECG data to detect various arrhythmias. This platform is best suited for streamlining cardiac diagnostics by efficiently identifying electrical abnormalities in patients over an extended monitoring period.
View Cardiologs Holter Platform →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | Cardiologs Holter Platform |
|---|---|---|
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Cloud |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiologs Holter PlatformThe Cardiologs Holter Platform (Tool B) is cloud-based, offering anytime, anywhere access and collaboration, which enhances flexibility and workflow. It also significantly reduces analysis time by approximately 42% and generates easy-to-read reports. Autoplaque (Tool A) is workstation-based, which can be less accessible and flexible for widespread use.
Clinical Value
TieBoth tools are FDA-cleared and offer substantial clinical value in their specialized domains. Autoplaque (Tool A) provides quantitative analysis of coronary plaques for heart attack risk prediction, backed by numerous peer-reviewed publications and validation studies. Cardiologs Holter Platform (Tool B) offers fast and accurate Holter ECG analysis, detecting over 20 arrhythmias with demonstrated reductions in false positives and increased sensitivity, performing at levels equivalent to a board-certified cardiologist.
Pricing & Value
Cardiologs Holter PlatformThe Cardiologs Holter Platform (Tool B) offers a transparent pricing model, stating 'Pay per ECG regardless the number of users.' This provides clarity on how costs are structured. Autoplaque (Tool A) has not disclosed its pricing, making it difficult to assess its value proposition.
Enterprise Readiness
Cardiologs Holter PlatformCardiologs Holter Platform (Tool B) demonstrates strong enterprise readiness with explicit HIPAA compliance, BAA availability, EMR integration (Philips IntelliBridge Enterprise), and secure ISO/IEC 27001 certified cloud hosting. Autoplaque (Tool A) is workstation-based and lacks specified HIPAA compliance, BAA, or EMR integration details in the provided information.
Innovation
TieBoth tools showcase significant innovation in their respective fields. Autoplaque (Tool A) offers advanced AI-powered quantitative analysis of coronary plaques from CT angiography for heart attack risk prediction. Cardiologs Holter Platform (Tool B) is a pioneer as the first FDA-cleared ECG analysis solution powered by deep learning, providing a vendor-neutral, cloud-based platform for comprehensive arrhythmia detection.
Support & Docs
Cardiologs Holter PlatformCardiologs Holter Platform (Tool B) provides clear avenues for technical support through its platform's 'Help' menu and offers accessible documentation like brochures and white papers. Autoplaque (Tool A) only mentions that minimum hardware specifications are in a user manual, without detailing specific support channels or comprehensive public documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | Cardiologs Holter Platform |
|---|---|---|
| Name | Autoplaque | Cardiologs Holter Platform |
| Company | Cedars-Sinai Medical Center: AIM | Philips France Commercial |
| Description | Autoplaque, developed by Cedars-Sinai AIM, is an FDA-cleared AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | The Cardiologs Holter Platform by Philips is an AI-powered, cloud-based solution for fast and accurate Holter ECG analysis, designed to detect over 20 types of arrhythmias and streamline cardiac diagnostics for healthcare professionals. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Radiology | Cardiology |
| Key Features (Partial) | AI-powered quantitative analysis of atherosclerotic plaque, Detection and characterization of coronary artery plaque, Measurement of luminal stenoses | AI-powered deep learning technology for ECG analysis, Cloud-based platform for anytime, anywhere access, Vendor-neutral compatibility with multiple Holter devices |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and Cardiologs Holter Platform.